Intercept Pharmaceuticals, Inc. (ICPT) Stock Rating Lowered by UBS AG
Among 20 analysts covering Intercept Pharmaceuticals (NASDAQ: ICPT ), 12 have Buy rating, 4 Sell and 4 Hold. Previously on 9/15/2017, RBC Capital reported about Intercept Pharma (NASDAQ: ICPT ) ...